73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers

RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers

byOsaka UniversityGraphical abstracts. REST_SSO directly modifies REST splicing and RE1 gene expression, whereas both REST_SSO and SRRM4_ASO exhibit antitumor effects in SCLC/NEPCa. Credit: 2024

RNA splicing strategy corrects tumor suppressor gene in neuroendocrine cancers

byOsaka UniversityGraphical abstracts. REST_SSO directly modifies REST splicing and RE1 gene expression, whereas both REST_SSO and SRRM4_ASO exhibit antitumor effects in SCLC/NEPCa. Credit: 2024
Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H
Early supper associated with lower risk of breast and prostate cancer

Early supper associated with lower risk of breast and prostate cancer

by Barcelona Institute for Global HealthEarly supper associated with breast and prostate cancer risk. Credit: ISGlobalHaving an early supper or leaving an interval of at least two hours before going t

Early supper associated with lower risk of breast and prostate cancer

by Barcelona Institute for Global HealthEarly supper associated with breast and prostate cancer risk. Credit: ISGlobalHaving an early supper or leaving an interval of at least two hours before going t
Cellular power-up: Stem cells provide T cells a lifeline as cancer champions

Cellular power-up: Stem cells provide T cells a lifeline as cancer champions

by University of Los AndesExperimental workflow of MitoT to native and CAR engineered T cells. Credit:Journal of Translational Medicine(2024). DOI: 10.1186/s12967-024-05627-4In a pioneerin

Cellular power-up: Stem cells provide T cells a lifeline as cancer champions

by University of Los AndesExperimental workflow of MitoT to native and CAR engineered T cells. Credit:Journal of Translational Medicine(2024). DOI: 10.1186/s12967-024-05627-4In a pioneerin
Study shows how cancer gene tricks immune cells

Study shows how cancer gene tricks immune cells

by Krista Conger,Stanford UniversityMYC regulated St6galnac4 promotes display of the glycan disialyl-T. (A) Murine T-ALL cell surface sialic acids were quantified at various time points after do

Study shows how cancer gene tricks immune cells

by Krista Conger,Stanford UniversityMYC regulated St6galnac4 promotes display of the glycan disialyl-T. (A) Murine T-ALL cell surface sialic acids were quantified at various time points after do
A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno
ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t
Researchers discuss HER2-low and HER2-zero in breast cancer

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot

Researchers discuss HER2-low and HER2-zero in breast cancer

by Impact Journals LLCMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumor beyond the lymph node. Credit: Nephron/WikipediaA new editorial paper titled &quot
Rethinking existing method opens new doors for cancer diagnostics

Rethinking existing method opens new doors for cancer diagnostics

by Osaka UniversityOperating principle of single-molecule quantum sequencing. Credit: Osaka UniversityAll diseases have a genetic component. Advances in understanding the genetic mechanisms behin

Rethinking existing method opens new doors for cancer diagnostics

by Osaka UniversityOperating principle of single-molecule quantum sequencing. Credit: Osaka UniversityAll diseases have a genetic component. Advances in understanding the genetic mechanisms behin
Maternal obesity linked to childhood cancer

Maternal obesity linked to childhood cancer

by University of PittsburghCredit: CC0 Public DomainA new study from the University of Pittsburgh Graduate School of Public Health and UPMC Hillman Cancer Center found that children born to obese

Maternal obesity linked to childhood cancer

by University of PittsburghCredit: CC0 Public DomainA new study from the University of Pittsburgh Graduate School of Public Health and UPMC Hillman Cancer Center found that children born to obese
Software tool analyzes cancer cells in biopsy slides

Software tool analyzes cancer cells in biopsy slides

by Quinn Eastman,Emory UniversityWorkflow of METI. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51708-9An innovative software tool could advance cancer pathology by pr

Software tool analyzes cancer cells in biopsy slides

by Quinn Eastman,Emory UniversityWorkflow of METI. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51708-9An innovative software tool could advance cancer pathology by pr
Targeted therapy slows progression of advanced prostate cancer

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical

Targeted therapy slows progression of advanced prostate cancer

by European Society for Medical OncologyProf Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA, study author Credit: © European Society for Medical